Compositions and methods for inhibiting viral vector-induced inflammatory responses
AssigneePresident and Fellows of Harvard College
InventorsYing Kai Chan, George M. Church
Life of this patent
Estimating the term…
Abstract
Provided herein, in some embodiments, are recombinant viral genomes comprising an inhibitory oligonucleotide that reduces inflammation for use, for example, in gene therapy.
Claims35
A method comprising administering to a muscle tissue of a subject a recombinant viral genome comprising a therapeutic nucleotide sequence and an inhibitory oligonucleotide that inhibits nucleic acid-sensing toll-like receptor (TLR) activation and/or signaling, wherein the recombinant viral genome inhibits an inflammatory response to the recombinant viral genome in the muscle tissue.
A recombinant viral genome comprising a therapeutic nucleotide sequence and an inhibitory oligonucleotide that comprises the nucleotide sequence of any one of SEQ ID NOS:
- 2-5, 7, 10-25, or 27-32.
A recombinant viral genome comprising a therapeutic nucleotide sequence and an inhibitory oligonucleotide that comprises the nucleotide sequence of SEQ ID NO:
- 35 (3×telomere), SEQ ID NO:
- 39 (3×telo3×INH18), and/or SEQ ID NO:
- 40 (3×4084-F3×2088).
Dependencies are inferred from the claim text.